Bath & Body Works, Inc.
For the period ended Aug 2, 2025. Filed Aug 28, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Aug 2, 2025 · Filed Aug 28, 2025
BBWI$21.65-0.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Cash Flows (Unaudited)
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in millions)
| Year-to-Date | ||
|---|---|---|
| 2025 | 2024 | |
| Operating Activities: | ||
| Net Income | $169 | $239 |
| Adjustments to Reconcile Net Income to Net Cash Provided by Operating Activities: | ||
| Depreciation of Long-lived Assets | 128 | 142 |
| Share-based Compensation Expense | 18 | 22 |
| Gain on Sales of Easton Investments | — | (39) |
| Deferred Income Taxes | (1) | (102) |
| Changes in Assets and Liabilities: | ||
| Accounts Receivable | 75 | 78 |
| Inventories | (241) | (154) |
| Accounts Payable, Accrued Expenses and Other | 157 | (67) |
| Income Taxes Payable | (139) | (79) |
| Other Assets and Liabilities | (21) | (10) |
| Net Cash Provided by Operating Activities | 145 | 30 |
| Investing Activities: | ||
| Capital Expenditures | (93) | (101) |
| Proceeds from Sales of Easton Investments | — | 50 |
| Other Investing Activities | (2) | 11 |
| Net Cash Used for Investing Activities | (95) | (40) |
| Financing Activities: | ||
| Payments for Long-term Debt | — | (202) |
| Repurchases of Common Stock | (254) | (248) |
| Dividends Paid | (85) | (90) |
| Tax Payments Related to Share-based Awards | (8) | (15) |
| Other Financing Activities | (15) | (5) |
| Net Cash Used for Financing Activities | (362) | (560) |
| Effects of Exchange Rate Changes on Cash and Cash Equivalents | 2 | — |
| Net Decrease in Cash and Cash Equivalents | (310) | (570) |
| Cash and Cash Equivalents, Beginning of Year | 674 | 1,084 |
| Cash and Cash Equivalents, End of Period | $364 | $514 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.